ライフサイエンスコーパス: ECG finding

1 ificantly greater than for those with normal ECG findings.

2 G changes and 8 athletes (4.6%) had abnormal ECG findings.

3 ummarized, and associations between specific ECG findings and cardiac allograft use for transplantati

4 was constructed using a propensity score for ECG findings and data on demographics, medical history,

5 ed the relationship between missed high-risk ECG findings and evidence-based therapy in the ED after

6 uded inter-ventricular hypertrophy, abnormal ECG findings and the R58Q mutation caused multiple cases

7 sentation after symptom onset, less specific ECG findings, and hospital presentation during off-hours

8 Initial ECG findings are not reliable in detecting patients with

9 Of 9 ECG findings assessed, none effectively distinguished th

10 mission day, including shock, heart failure, ECG findings, cardiovascular disease history, kidney fun

11 d a Wenckebach type I AV block; in the third ECG, findings compatible with simultaneous conduction al

12 ach infant demonstrated unique and transient ECG findings consisting of ST changes and QRS widening b

13 The primary end point was false-positive ECG findings, defined as the percentage of patients with

14 d with a higher percentage of false-positive ECG findings for STEMI.

15 ostic initial clinical or electrocardiogram (ECG) findings for acute cardiac ischemia, continuous 12-

16 stroke in V1 through V3 is the most frequent ECG finding in ARVD/C and should be considered as a diag

17 valence of the failure to identify high-risk ECG findings in ED patients with AMI and to determine wh

18 The failure to identify high-risk ECG findings in patients with AMI results in lower-quali

19 e performed the first comprehensive study of ECG findings in potential donors for cardiac transplanta

20 However, little is known about the expected ECG findings in potential organ donors or the clinical s

21 The percentage of false-positive ECG findings in the first tertile of ROSC to ECG time (

22 the potential value of including nonspecific ECG findings in the overall assessment of cardiovascular

23 Among patients with missed high-risk ECG findings, in-hospital mortality was 7.9% compared wi

24 Abnormal ECG findings included T-wave inversions (3 athletes [1.7

25 toring increases the detection of diagnostic ECG findings, including ST-segment elevation, in patient

26 ng athletes with at least 1 training-related ECG finding, left ventricular structural adaptations ass

27 were analyzed with concentration cut-points, ECG findings, logistic regression (LR) (adjusted for mat

28 When ECG findings, salivary biomarkers, and confounders were

29 sented within 12 hours of symptom onset with ECG findings (ST-segment elevation) consistent with AMI

30 years of age) and presenting with a positive ECG finding suggestive of 1 of the 3 most common pediatr

31 as the percentage of patients with post-ROSC ECG findings that met STEMI criteria but who did not sho

32 or prediction of CHD events, the addition of ECG findings to the Framingham risk score increased from

33 Abnormal ECG findings were more common in female athletes, while

34 High-risk ECG findings were not documented in 201 patients (12%).

35 lated findings were common, whereas abnormal ECG findings were rare in this athlete group.

36 Normal training-related and abnormal ECG findings were reported using the International Recom

37 higher prevalence of normal training-related ECG findings, while female athletes were more likely to

38 collected makes it possible to correlate the ECG findings with the anatomy, composition and electroph